- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06121193
Using Interventional Informatics to Address Social Determinants of Health During Clinical Care Visits to Promote Behavior Change and PREVENT Cardiovascular Disease
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Missouri
-
Saint Louis, Missouri, United States, 63130
- Washington University in St. Louis
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 12-17 years at baseline
- at risk for poor CVH (body mass index >= 85th percentile)
- Receiving care from the Healthy Start Clinic at Barnes Jewish Hospital.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Patients - Wait-List Control
Complete questionnaires at baseline (administered electronically or by mail). Follow-up measures will be administered at 3-months after the clinic visit electronically and by mail. • A PREVENT action plan (behavior change prescription, community resources, and education) will be provided to the patient via email after the completion of the follow-up measurement. |
Will receive routine clinical care.
After completion of follow-up measures, control participants will receive a behavior change prescription via the PREVENT tool
|
Experimental: Experimental: Patients - PREVENT Tool
Complete questionnaires at baseline (administered electronically or by mail). Follow-up measures will be administered immediately following the clinic visit, and monthly for 3-months after the clinic visit electronically and by mail • At the clinic visit, the provider will use the PREVENT tool to discuss CVH risk and deliver a tailored behavioral change plan inclusive of patient-centered community resources. |
PREVENT is a novel Health Information Technology tool designed to promote physical activity and healthy food intake among overweight/obese patients at the point of care.
PREVENT automates the delivery of personalized, evidence-based behavior change recommendations and provides an interactive map of community resources to help providers link patients to resources in their community.
|
No Intervention: Providers
-All eligible providers will be sent questionnaires electronically to their email at baseline, following provider training and follow-up.
Providers will be invited to attend a training session to educate them on the PREVENT tool at baseline.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fidelity of PREVENT tool implementation
Time Frame: 0-3 months
|
Fidelity will be measured using direct observation of patient-provider interactions while using the PREVENT tool.
A direct observation checklist will be used by the observer to determine the number of interactions with the PREVENT tool that were implemented as intended.
|
0-3 months
|
Patients' satisfaction of PREVENT tool: survey
Time Frame: 3-months
|
A survey (6-questions) will assess patient's satisfaction with the PREVENT tool.
Questions are asked on a 5-point Likert scale (range: 6-30) with a higher score indicating greater satisfaction.
|
3-months
|
Provider's satisfaction of PREVENT tool: survey
Time Frame: 3-months
|
A survey (31-questions) will assess provider's acceptability and satisfaction with five aspects of health information technology: content, accuracy, format, ease of use and timeliness.
Questions are asked on a 5-point Likert scale (range: 31-155) with a higher score indicating greater satisfaction.
|
3-months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in patient's motivation
Time Frame: At baseline, and 3-months
|
A survey (15-question) administered to patients will assess motivation and self-efficacy for behavior change.
Questions are asked using a 4-point Likert scale (range: 15-60) with a higher score indicating greater motivation.
|
At baseline, and 3-months
|
Change in patient's knowledge of CVH
Time Frame: At baseline, and 3-months
|
A survey (3-question) administered to patients to assess their knowledge of CVH risk (perceived value/importance of healthy behaviors) and awareness of resources.
Questions are asked using a 4-point Likert scale (range: 3-12) with a higher score indicating greater knowledge.
|
At baseline, and 3-months
|
Change in food intake behaviors
Time Frame: At baseline, and 3-months
|
Patient-reported food intake behaviors (fruit and vegetable intake, whole grains, sugar-sweetened beverages and snacking behaviors) are collected using a brief Health Behavior & Attitudes Survey.
|
At baseline, and 3-months
|
Change in physical activity behaviors
Time Frame: At baseline, and 3-months
|
Patient-reported physical activity (minutes of moderate and vigorous activity per week) are collected using a survey (4-questions).
Patients report the average number of minutes of moderate and vigorous activity they do per week.
|
At baseline, and 3-months
|
Change in body mass index z-score
Time Frame: At baseline, and 3-months
|
Collected from patient's medical record.
BMI z-score was calculated using the Centers for Disease Control and Prevention Growth Charts.
The mean change was calculated by subtracting the baseline mean from the follow-up mean for each intervention group.
|
At baseline, and 3-months
|
Change on patient's average systolic and diastolic blood pressure
Time Frame: At baseline, and 3-months
|
Collected from patient's medical record
|
At baseline, and 3-months
|
Change in patient's cholesterol
Time Frame: At baseline, and 3-months
|
Collected from patient's medical record
|
At baseline, and 3-months
|
Change in patient's blood glucose
Time Frame: At baseline, and 3-months
|
Collected from patient's medical record
|
At baseline, and 3-months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202004230
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Medical College of WisconsinRecruitingCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
VA Office of Research and DevelopmentNot yet recruitingCardiovascular DiseaseUnited States
-
Baptist Health South FloridaUniversity of California, Los Angeles; Quest Diagnostics-Nichols InsituteActive, not recruitingCardiovascular DiseaseUnited States
-
Laval UniversityActive, not recruitingCardiovascular DiseaseCanada
-
Penn State UniversityCalifornia Healthcare InstituteCompleted
Clinical Trials on Wait-list Control
-
New York State Psychiatric InstituteCompletedCognitive Deterioration | Disorder of AgingUnited States
-
University of OsloNorwegian Institute of Public Health; Norwegian Council for Mental Health; The...CompletedQuality of Life | Wellbeing | Health AttitudeNorway
-
New York State Psychiatric InstituteFeinstein Institute for Medical ResearchCompleted
-
University of Alabama at BirminghamNational Cancer Institute (NCI)Completed
-
Kaohsiung Medical University Chung-Ho Memorial...Kaohsiung Medical UniversityUnknownHead and Neck CancerTaiwan
-
Macmillan Research Group UKNMP Medical Research Institute; Warwick Research ServicesUnknownRheumatic ArthritisIndia
-
Washington University School of MedicineNot yet recruitingCardiovascular Diseases | ObesityUnited States
-
VA Office of Research and DevelopmentRecruitingSuicide | Mental HealthUnited States
-
Seattle Children's HospitalCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Gynecologic Cancer | Peripheral NeuropathyUnited States